Subcision With CO₂ Laser or PRP vs Subcision Alone in Atrophic Acne Scars
A Combined Subcision Approach With Either Fractional CO₂ Laser or Platelet-rich Plasma Versus Subcision Alone in the Treatment of Atrophic Post-acne Scars
1 other identifier
interventional
42
1 country
1
Brief Summary
Acne vulgaris is an inflammatory disease of pilosebaceous unit ,leading to different types of scars including atrophic, hypertrophic and keloidal. Atrophic scars are the most common type ,affecting about 75-90% of acne scar cases and can be ice pick, rolling or boxcar in morphology . Theses scars may cause significant impact such as depression, anxiety , and reduced quality of life. multiple treatment modalities exist, including lasers ,chemical peels, dermabrasion, microneedling, subcision and platelet rich plasma. Subcision is a well established technique that improves rolling and boxcar scars by releasing fibrotic strands. Fractional co2 laser induces dermal remodeling and collagen neogenesis, while PRP enhances wound healing and collagen induction through growth factors. Combinig subcision with either co2 laser or PRP may enhance treatment efficacy compared to subcision alone. rational : Subcision alone may provide limited improvement in some patients. Fractional CO₂ laser and PRP are promising adjunctive modalities that could enhance collagen remodeling and improve cosmetic outcomes. Evaluating their combined effect versus subcision alone will help determine the most effective and safe approach for managing atrophic post-acne scars. aim of work:To compare the efficacy and safety of combined subcision with either fractional CO₂ laser or platelet-rich plasma versus subcision alone in the treatment of facial atrophic post-acne scars.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2025
CompletedFirst Posted
Study publicly available on registry
September 30, 2025
CompletedStudy Start
First participant enrolled
November 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
October 3, 2025
September 1, 2025
1 year
September 22, 2025
September 30, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Goodman and Baron quantitative acne scar score (Baseline vs 1 month post last session).
If the scale was lowered by: (Quantitative) 0-5 points, the reduction will be considered minimal 5-10 points, it will be considered moderate reduction 10-15 points, it will be considered good reduction \>15 points, it will be considered very good reduction
3 sessions per patient at 1-month intervals Follow-up: 1 month after last session
Secondary Outcomes (1)
Quartile grading scale improvement - Dermoscopic evaluation (erythema, pigmentation, photodamage, follicle density)
3 sessions per patient at 1-month intervals Follow-up: 1 month after last session
Study Arms (3)
subcision alone
ACTIVE COMPARATORsubcision+fractional co2 laser
EXPERIMENTALsubcision+platelet rich plasma
EXPERIMENTALInterventions
patients will undergo subcision procedure alone using 18 gauge blunt cannula to release fibrous bands under atrophic acne scars.this group will serve as control comparator
patients will undergo subcision procedure followed by fractional co2 laser applied to right side of face, the left side will receive subcision alone
patients will undergo subcision procedure followed by intradermal injection of autologous PRP prepared from patients blood on right side.left side will receive subcision alone
Eligibility Criteria
You may qualify if:
- \- Adult patients of both sexes with mild to severe atrophic post-acne scars.
You may not qualify if:
- \- Age \< 18 years
- Pregnant or lactating women
- Active inflammatory acne or infection in treatment area
- Premalignant or malignant lesions
- Photosensitive dermatoses
- Coagulation defects or blood disease
- History of keloid scars
- Systemic retinoid use in previous 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut University Hospitals, Dermatology Department
Asyut, Asyut Governorate, Egypt
Related Publications (2)
Tran BQ, Tran TNA, Doan EVL, Nguyen TTP, Nguyen HT. Simultaneous versus sequential fractional CO2 laser and subcision combination for management of post-acne atrophic scars: A split-face comparative study. J Cosmet Dermatol. 2024 Oct;23(10):3210-3221. doi: 10.1111/jocd.16395. Epub 2024 May 21.
PMID: 38770894BACKGROUNDAbdelwahab AA, Omar GAB, Hamdino M. A combined subcision approach with either fractional CO2 laser (10,600 nm) or cross-linked hyaluronic acid versus subcision alone in atrophic post-acne scar treatment. Lasers Med Sci. 2022 Dec 24;38(1):20. doi: 10.1007/s10103-022-03677-y.
PMID: 36564573BACKGROUND
Related Links
Study Officials
- STUDY CHAIR
Azza Mahfouz Abdel Meguid
Assiut University
- STUDY DIRECTOR
Reham Maher Abd El Gaber
Assiut University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
September 22, 2025
First Posted
September 30, 2025
Study Start
November 1, 2025
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
January 1, 2027
Last Updated
October 3, 2025
Record last verified: 2025-09